(InfinityQS International: Chantilly, Virginia) -- Saving the lives of children who have suffer from pediatric cancer and other catastrophic childhood diseases was the goal for InfinityQS when the company committed to donate $1 million to St. Jude Children’s Research Hospital.
“We chose to direct all of our charitable giving to a single organization so that we could maximize our impact,” says Michael A. Lyle, president and CEO of InfinityQS. “After visiting St. Jude Children’s Research Hospital on several occasions, we were able to see first-hand how our contributions were helping save children’s lives every day.”
InfinityQS, a provider of SPC software and services to help manufacturers to monitor, control, and improve the quality of their manufacturing operations has already donated $250,000 of the $1 million commitment to support St. Jude’s groundbreaking research and lifesaving care since identifying the hospital as its sole charitable partner in 2005.
The company's gift has already helped St. Jude make tremendous strides in its mission to find cures and save children. St. Jude’s development of combination therapy for children with acute lymphoblastic leukemia (ALL), the most common form of childhood cancer, revolutionized leukemia therapy worldwide and increased the survival rate from 4 percent, when St. Jude opened in 1962, to 94 percent today. St. Jude’s innovative research has also led to a dramatic increase in survival rates for children with many other major forms of cancer.
Founded by late entertainer Danny Thomas and based in Memphis, St. Jude freely shares its discoveries with scientific and medical communities around the world. St. Jude is the only pediatric cancer research center where families never pay for treatment not covered by insurance. No child is ever denied treatment because of the family’s inability to pay.
For further information, visit www.infinityqs.com or www.stjude.org.
Add new comment